Medium materiality6/10
Emerson price target lowered to $170 from $185 at KeyBanc
Why it may matterVerify against the original reporting
Lower target implies weaker near-term prospects.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
KeyBanc trims EMR target to $170 from $185; current price $138.88. Bearish tilt implied by the downgrade.
- Target lowered; price 138.88; KeyBanc.
Key facts
- 01
Target: $170
- 02
Posted price: $138.88
- 03
Analyst firm: KeyBanc
- 04
Analyst: Ken Newman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.